Open Now: The Global ETF Survey Take the Survey →

Advertisement
Advertisement

IHEvsVHTETF Comparison

ETF 1
IHE

iShares U.S. Pharmaceuticals ETF

This fund is part of
US Health Care
+0.4%
VS
ETF 2
VHT

Vanguard Health Care ETF

This fund is part of
US Health Care
+0.4%

iShares U.S. Pharmaceuticals ETF (IHE) and Vanguard Health Care ETF (VHT) belong to the same industry segment: US Health Care. IHE's top 3 sector exposures are Healthcare and Non-Corporate. In contrast, VHT's top sector exposures are Healthcare and Consumer Non-Cyclicals.Business Services,  IHE is more expensive with a Total Expense Ratio (TER) of 0.38%, versus 0.09% for VHT. IHE is up 21% year-to-date (YTD) with +$434M in YTD flows. VHT performs worse with 6.18% YTD performance, and -$99M in YTD flows. Run a side-by-side ETF comparison of IHE and VHT below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

IHE vs VHT performance and flow charts

Performance

0246810%Jun 23Jun 30Jul 8Jul 15Jul 22

Cumulative Flows

0 M100 M200 M300 M400 MJun 23Jun 30Jul 8Jul 15Jul 22

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 07/23/2026
1M3MYTD1Y3Y5Y
Perf.
IHE
VHT
+8.25%+6.20%
+17.70%+11.48%
+21.00%+6.18%
+49.98%+22.78%
+76.25%+27.13%
+74.85%+27.80%
Flows
IHE
VHT
+$399M+$140M
+$357M+$120M
+$434M-$99M
+$588M-$348M
+$682M-$2.44B
+$698M-$688M
Volatility and drawdown
3M1Y3Y5Y
Volatility
IHE
VHT
+21.33%+17.66%
+18.06%+15.30%
+16.91%+14.31%
+16.50%+15.40%
Max drawdown
IHE
VHT
-4.42%-3.84%
-8.48%-10.39%
-16.04%-16.88%
-16.12%-17.77%
Max drawdown duration
IHE
VHT
16d16d
81d169d
210d435d
669d767d
Trading data

Create an account to view trading data

Join for free
IHE
VHT
Last sale
7/23/2026 at 1:30 PM
$101.99
$303.31
Previous close
07/23/2026
$100.64
$299.80
Consolidated volume
07/23/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of June 30, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
IHE
VHT
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 7/23/2026 at 1:30 PM
Live
Closed
IHE
VHT
Last price
$101.99
$303.31
1D performance
+1.34%
+1.17%
AuM$1.47 B$18.15 B
E/R0.38%0.09%
Characteristics
IHE
VHT
Management strategyPassivePassive
ProvideriSharesVanguard
BenchmarkDow Jones U.S. Select Pharmaceuticals IndexMSCI US IMI Health Care 25/50 Index
N° of holdings57419
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateMay 1, 2006January 26, 2004
ESGNoNo
Advertisement
Exposure

Countries

IHE
USA
96.01%
Other
3.99%
VHT
USA
96.86%
Other
3.14%

Sectors

IHE
Healthcare
99.92%
Other
0.08%
VHT
Healthcare
97.39%
Other
2.61%
Advertisement

Diversification

IHE

Total weight of top 15 holdings out of 15

84.53%
VHT

Total weight of top 15 holdings out of 15

61.42%

Top 15 holdings

Data as of June 30, 2026
IHE
Johnson & Johnson
22.44%
Eli Lilly & Co.
22.25%
Merck & Co., Inc.
4.55%
Bristol Myers Squibb Co.
4.37%
Royalty Pharma Plc
4.33%
Viatris, Inc.
4.22%
Pfizer Inc.
3.96%
Zoetis, Inc.
3.73%
Jazz Pharmaceuticals Plc
3.45%
Elanco Animal Health, Inc.
2.81%
Axsome Therapeutics, Inc.
2.41%
Corcept Therapeutics, Inc.
1.90%
Ligand Pharmaceuticals, Inc.
1.45%
Definium Therapeutics, Inc.
1.39%
Liquidia Corp.
1.28%
VHT
Eli Lilly & Co.
14.16%
Johnson & Johnson
8.87%
AbbVie, Inc.
6.54%
UnitedHealth Group, Inc.
5.55%
Merck & Co., Inc.
4.67%
Amgen, Inc.
2.87%
Thermo Fisher Scientific, Inc.
2.74%
Abbott Laboratories
2.32%
Gilead Sciences, Inc.
2.31%
Intuitive Surgical, Inc.
2.08%
Pfizer Inc.
2.01%
CVS Health Corp.
1.93%
Vertex Pharmaceuticals, Inc.
1.86%
Danaher Corp.
1.78%
Bristol Myers Squibb Co.
1.73%
Frequently asked questions about IHE and VHT

How have the IHE and VHT ETFs performed in 2026?

As of July 23, 2026, IHE is up 21% year-to-date (YTD), while VHT has returned 6.18%. That puts IHE better performer ahead so far this year.

Which ETF is attracting more investor money: IHE or VHT?

Year-to-date, the IHE ETF saw +$434M in flows, compared to -$99M for VHT.

Which ETF is more volatile: IHE or VHT?

Over the past year, IHE had a volatility of 18.06%, while VHT experienced 15.3%.

Which ETF is bigger: IHE or VHT?

As of July 23, 2026, IHE holds $1.47 B in assets under management (AUM), while VHT manages $18.15 B.

What sectors do the IHE and VHT ETFs invest in?

IHE leans toward sectors like Healthcare. Meanwhile, VHT focuses on Healthcare.

What are the top holdings of the IHE ETF and VHT ETF?

IHE top holdings include Johnson & Johnson, Eli Lilly & Co. and Merck & Co., Inc.. VHT holds in its top three: Eli Lilly & Co., Johnson & Johnson and AbbVie, Inc..

Which ETF is more diversified: IHE or VHT?

IHE holds 57 securities with 84.53% of its assets in the top 15. VHT has 419 securities and a top 15 weight of 61.42%.

Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder